Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children
Schistosomiasis is a major public health problem in Africa. However, it is only recently that its burden has become recognised as a significant component impacting on the health and development of preschool-aged children. A longitudinal study was conducted in Zimbabwean children to determine the eff...
Main Authors: | Welcome M. Wami, Norman Nausch, Nicholas Midzi, Reggis Gwisai, Takafira Mduluza, Mark E. J. Woolhouse, Francisca Mutapi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2016/9162631 |
Similar Items
-
Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.
by: Welcome M Wami, et al.
Published: (2015-03-01) -
Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
by: Mark S. Pearson, et al.
Published: (2021-05-01) -
Immunological Consequences of Antihelminthic Treatment in Preschool Children Exposed to Urogenital Schistosome Infection
by: Nadine Rujeni, et al.
Published: (2013-01-01) -
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011-05-01) -
Putting the treatment of paediatric schistosomiasis into context
by: Takafira Mduluza, et al.
Published: (2017-04-01)